查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1762257

神經刺激設備市場、規模、佔有率、趨勢、產業分析報告：依應用、設備、地區、市場預測2025-2034

Neurostimulation Devices Market Size, Share, Trends, Industry Analysis Report: By Application, Devices, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，全球神經刺激設備市場預計到2034年將達到 236.3億美元。本研究報告對當前市場動態提供了詳細的見解，並對未來的市場成長進行了分析。

神經刺激設備市場包括向神經系統傳遞電脈衝以調節神經活動的醫療設備，主要用於治療慢性疼痛、癲癇、帕金森氏症、特發性震顫和其他神經系統疾病。

由於神經系統疾病盛行率上升、對微創治療方案的需求增加以及人工智慧整合和無線刺激等技術進步，市場經歷顯著成長。神經刺激設備的市場機會在於這些設備在新興市場的日益普及，以及其用途超越認知障礙和肥胖管理等傳統適應症的擴展。

主要趨勢包括可充電和小型化設備的發展、行業參與者之間的策略聯盟以及推動神經刺激設備市場擴張的監管部門的批准。隨著醫療保健基礎設施的改善和意識的提高，在技術創新和不斷變化的患者需求的推動下，市場穩步成長。

神經刺激設備市場報告重點

根據應用，由於慢性疼痛症盛行率上升和脊髓刺激器的採用率增加，疼痛管理領域佔據了最大的市場佔有率。

依裝置類型，深部腦部刺激設備是成長最快的類別，這得益於其在帕金森氏症和特發性震顫等運動障礙方面的應用不斷擴大。

由於高昂的醫療保健支出、強有力的監管批准以及神經刺激設備的廣泛採用，北美在市場中處於領先地位。

隨著醫療保健基礎設施的改善、意識的增強以及神經系統疾病盛行率的上升，亞太地區經歷顯著的成長。

神經刺激設備市場有幾個關鍵參與者積極為醫療技術的進步做出貢獻。主要公司包括Abbott Laboratories、Aleva Neurotherapeutics、Boston Scientific Corporation、Cognito Therapeutics、ElectroCore, Inc、LivaNova PLC、Medtronic plc、Nalu Medical, Inc、Neuronetics, Inc、NeuroPace, Inc、Nevro Corp、Synapse Biomedical Inc。

目錄

第1章 簡介

第2章 執行摘要

第3章 研究方法

第4章 全球神經刺激設備市場洞察

  • 市場概況
  • 神經刺激設備市場動態
    • 驅動因素和機會
      • 神經系統疾病盛行率不斷上升
      • 神經刺激技術的進步
    • 抑制因素和挑戰
      • 設備和程式成本高昂
  • PESTEL 分析
  • 神經刺激設備的市場趨勢
  • 價值鏈分析
  • COVID-19 影響分析

第5章 全球神經刺激設備市場（依應用）

  • 主要調查結果
  • 簡介
  • 疼痛管理
  • 癲癇
  • 特發性震顫
  • 尿失禁及大便失禁
  • 憂鬱症

第6章 全球神經刺激設備市場（依設備）

  • 主要調查結果
  • 簡介
  • 脊髓刺激裝置
  • 深部腦部刺激裝置
  • 薦神經刺激裝置
  • 迷走神經刺激裝置
  • 胃電刺激裝置

第7章 全球神經刺激設備市場（依地區）

  • 主要調查結果
  • 簡介
    • 神經刺激設備市場分析：地區，2020-2034
  • 北美
    • 北美：依應用，2020-2034年
    • 北美：依設備，2020-2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲，依應用，2020-2034年
    • 歐洲：依設備，2020-2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 亞太地區：依應用，2020-2034年
    • 亞太地區：依設備，2020-2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東和非洲
    • 中東和非洲：依應用，2020-2034年
    • 中東和非洲：依設備，2020-2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲地區
  • 拉丁美洲
    • 拉丁美洲：依應用，2020-2034年
    • 拉丁美洲：依設備，2020-2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家

第8章 競爭格局

  • 擴張與收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協議/公開

第9章 公司簡介

  • Abbott Laboratories
  • Advanced Bionics（a Sonova Group company）
  • Aleva Neurotherapeutics
  • Boston Scientific Corporation
  • Cochlear Limited
  • Cognito Therapeutics
  • ElectroCore, Inc.
  • Inspire Medical Systems, Inc.
  • LivaNova PLC
  • Medtronic plc
Product Code: PM3256

The global neurostimulation devices market size is expected to reach USD 23.63 billion by 2034, according to a new study by Polaris Market Research. The report "Neurostimulation Devices Market Size, Share, Trends, Industry Analysis Report: By Application (Pain Management, Epilepsy, Essential Tremor, Urinary & Faecal Incontinence, and Depression), Devices, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The neurostimulation devices market consists of medical devices that deliver electrical impulses to the nervous system to modulate neural activity, primarily used for managing chronic pain, epilepsy, Parkinson's disease, essential tremor, and other neurological conditions.

The market is experiencing significant growth due to the rising prevalence of neurological disorders, increasing demand for minimally invasive treatment options, and advancements in technology, including AI integration and wireless stimulation. Neurostimulation devices market opportunities lie in expanding applications beyond traditional indications, such as in cognitive disorders and obesity management, along with the growing adoption of these devices in emerging markets.

Key trends include the development of rechargeable and miniaturized devices, strategic collaborations among industry players, and regulatory approvals facilitating neurostimulation devices market expansion. As healthcare infrastructure improves and awareness increases, the market continues to witness steady growth, driven by innovation and evolving patient needs.

Neurostimulation Devices Market Report Highlights

By application, the pain management segment holds the largest market share due to the rising prevalence of chronic pain conditions and the increasing adoption of spinal cord stimulators.

By devices, the deep brain stimulators segment is experiencing the fastest growth, supported by their expanding use in movement disorders such as Parkinson's disease and essential tremor.

North America leads the market due to high healthcare spending, strong regulatory approvals, and widespread adoption of neurostimulation devices.

Asia Pacific is experiencing significant growth, driven by improving healthcare infrastructure, rising awareness, and increasing prevalence of neurological disorders.

The neurostimulation devices market features several key players actively contributing to advancements in medical technology. Prominent companies include Abbott Laboratories; Aleva Neurotherapeutics; Boston Scientific Corporation; Cognito Therapeutics; ElectroCore, Inc.; LivaNova PLC; Medtronic plc; Nalu Medical, Inc.; Neuronetics, Inc.; NeuroPace, Inc.; Nevro Corp.; and Synapse Biomedical Inc.

Polaris Market Research has segmented the neurostimulation devices market report on the basis of application, devices, and region:

By Application Outlook (Revenue - USD Billion, 2020-2034)

Pain Management

Epilepsy

Essential Tremor

Urinary & Faecal Incontinence

Depression

By Devices Outlook (Revenue - USD Billion, 2020-2034)

Spinal Cord Stimulator

Deep Brain Stimulator

Sacral Nerve Stimulator

Vagus Nerve Stimulator

Gastric Electric Stimulator

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Neurostimulation Devices Market Insights

  • 4.1. Neurostimulation Devices Market - Market Snapshot
  • 4.2. Neurostimulation Devices Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Neurological Disorders
      • 4.2.1.2. Advancements in Neurostimulation Technology
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Devices and Procedures
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Neurostimulation Devices Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Neurostimulation Devices Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • 5.3. Pain Management
    • 5.3.1. Global Neurostimulation Devices Market, by Pain Management, by Region, 2020-2034 (USD Billion)
  • 5.4. Epilepsy
    • 5.4.1. Global Neurostimulation Devices Market, by Epilepsy, by Region, 2020-2034 (USD Billion)
  • 5.5. Essential Tremor
    • 5.5.1. Global Neurostimulation Devices Market, by Essential Tremor, by Region, 2020-2034 (USD Billion)
  • 5.6. Urinary & Faecal Incontinence
    • 5.6.1. Global Neurostimulation Devices Market, by Urinary & Faecal Incontinence, by Region, 2020-2034 (USD Billion)
  • 5.7. Depression
    • 5.7.1. Global Neurostimulation Devices Market, by Depression, by Region, 2020-2034 (USD Billion)

6. Global Neurostimulation Devices Market, by Devices

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 6.3. Spinal Cord Stimulator
    • 6.3.1. Global Neurostimulation Devices Market, by Spinal Cord Stimulator, by Region, 2020-2034 (USD Billion)
  • 6.4. Deep Brain Stimulator
    • 6.4.1. Global Neurostimulation Devices Market, by Deep Brain Stimulator, by Region, 2020-2034 (USD Billion)
  • 6.5. Sacral Nerve Stimulator
    • 6.5.1. Global Neurostimulation Devices Market, by Sacral Nerve Stimulator, by Region, 2020-2034 (USD Billion)
  • 6.6. Vagus Nerve Stimulator
    • 6.6.1. Global Neurostimulation Devices Market, by Vagus Nerve Stimulator, by Region, 2020-2034 (USD Billion)
  • 6.7. Gastric Electric Stimulator
    • 6.7.1. Global Neurostimulation Devices Market, by Gastric Electric Stimulator, by Region, 2020-2034 (USD Billion)

7. Global Neurostimulation Devices Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Neurostimulation Devices Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Neurostimulation Devices Market - North America
    • 7.3.1. North America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.3.2. North America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.3.3. Neurostimulation Devices Market - U.S.
      • 7.3.3.1. U.S.: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.3.4. Neurostimulation Devices Market - Canada
      • 7.3.4.1. Canada: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.4. Neurostimulation Devices Market - Europe
    • 7.4.1. Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.3. Neurostimulation Devices Market - UK
      • 7.4.3.1. UK: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.4. Neurostimulation Devices Market - France
      • 7.4.4.1. France: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.5. Neurostimulation Devices Market - Germany
      • 7.4.5.1. Germany: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.6. Neurostimulation Devices Market - Italy
      • 7.4.6.1. Italy: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.7. Neurostimulation Devices Market - Spain
      • 7.4.7.1. Spain: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.8. Neurostimulation Devices Market - Netherlands
      • 7.4.8.1. Netherlands: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.9. Neurostimulation Devices Market - Russia
      • 7.4.9.1. Russia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.10. Neurostimulation Devices Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.5. Neurostimulation Devices Market - Asia Pacific
    • 7.5.1. Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.3. Neurostimulation Devices Market - China
      • 7.5.3.1. China: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.4. Neurostimulation Devices Market - India
      • 7.5.4.1. India: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.5. Neurostimulation Devices Market - Malaysia
      • 7.5.5.1. Malaysia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.6. Neurostimulation Devices Market - Japan
      • 7.5.6.1. Japan: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.7. Neurostimulation Devices Market - Indonesia
      • 7.5.7.1. Indonesia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.8. Neurostimulation Devices Market - South Korea
      • 7.5.8.1. South Korea: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.9. Neurostimulation Devices Market - Australia
      • 7.5.9.1. Australia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.10. Neurostimulation Devices Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.6. Neurostimulation Devices Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.6.3. Neurostimulation Devices Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.6.4. Neurostimulation Devices Market - UAE
      • 7.6.4.1. UAE: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.6.5. Neurostimulation Devices Market - Israel
      • 7.6.5.1. Israel: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.6.6. Neurostimulation Devices Market - South Africa
      • 7.6.6.1. South Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.6.7. Neurostimulation Devices Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.7. Neurostimulation Devices Market - Latin America
    • 7.7.1. Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.7.3. Neurostimulation Devices Market - Mexico
      • 7.7.3.1. Mexico: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.7.4. Neurostimulation Devices Market - Brazil
      • 7.7.4.1. Brazil: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.7.5. Neurostimulation Devices Market - Argentina
      • 7.7.5.1. Argentina: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.7.6. Neurostimulation Devices Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Abbott Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Advanced Bionics (a Sonova Group company)
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Aleva Neurotherapeutics
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Boston Scientific Corporation
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Cochlear Limited
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Cognito Therapeutics
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. ElectroCore, Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Inspire Medical Systems, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. LivaNova PLC
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Medtronic plc
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development

List of Tables:

  • Table 1 Global Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 2 Global Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 3 North America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 4 North America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 5 U.S.: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 6 U.S.: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 7 Canada: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 8 Canada: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 9 Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 10 Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 11 UK: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 12 UK: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 13 France: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 14 France: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 15 Germany: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 16 Germany: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 17 Italy: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 18 Italy: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 19 Spain: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 20 Spain: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 21 Netherlands: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 22 Netherlands: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 23 Russia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Russia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 25 Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 26 Rest of Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 27 Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 28 Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 29 China: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 30 China: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 31 India: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 32 India: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 33 Malaysia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 34 Malaysia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 35 Japan: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Japan: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 37 Indonesia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 38 Indonesia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 39 South Korea: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 40 South Korea: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 41 Australia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Australia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 43 Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 44 Rest of Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 45 Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 46 Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 47 Saudi Arabia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 48 Saudi Arabia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 49 UAE: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 50 UAE: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 51 Israel: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 52 Israel: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 53 South Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 54 South Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 55 Rest of Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 56 Rest of Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 57 Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 58 Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 59 Mexico: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 60 Mexico: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 61 Brazil: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 62 Brazil: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 63 Argentina: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 64 Argentina: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Neurostimulation Devices Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Neurostimulation Devices Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Devices
  • Figure 9. Global Neurostimulation Devices Market, by Devices, 2024 & 2034 (USD Billion)